Intuitive Surgical, Inc. (NASDAQ:ISRG) Short Interest Update

Intuitive Surgical, Inc. (NASDAQ:ISRGGet Free Report) was the target of a large growth in short interest in the month of March. As of March 15th, there was short interest totalling 3,570,000 shares, a growth of 8.2% from the February 29th total of 3,300,000 shares. Based on an average trading volume of 1,630,000 shares, the short-interest ratio is currently 2.2 days.

Insider Activity at Intuitive Surgical

In related news, Director Alan J. Levy sold 2,000 shares of the business’s stock in a transaction that occurred on Friday, January 26th. The shares were sold at an average price of $370.20, for a total transaction of $740,400.00. Following the completion of the transaction, the director now owns 25,319 shares in the company, valued at $9,373,093.80. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. In other news, VP Marshall Mohr sold 108,790 shares of Intuitive Surgical stock in a transaction dated Wednesday, February 28th. The stock was sold at an average price of $385.08, for a total transaction of $41,892,853.20. Following the transaction, the vice president now owns 26,877 shares in the company, valued at approximately $10,349,795.16. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Alan J. Levy sold 2,000 shares of the stock in a transaction on Friday, January 26th. The stock was sold at an average price of $370.20, for a total transaction of $740,400.00. Following the sale, the director now directly owns 25,319 shares of the company’s stock, valued at approximately $9,373,093.80. The disclosure for this sale can be found here. Insiders have sold 248,418 shares of company stock worth $95,927,097 in the last ninety days. Company insiders own 0.80% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. Nomura Holdings Inc. acquired a new stake in shares of Intuitive Surgical during the fourth quarter worth $3,049,000. HighPoint Advisor Group LLC bought a new position in Intuitive Surgical during the fourth quarter worth about $1,181,000. Sivia Capital Partners LLC acquired a new stake in Intuitive Surgical in the 4th quarter worth about $245,000. PVG Asset Management Corp acquired a new position in shares of Intuitive Surgical during the 4th quarter worth approximately $202,000. Finally, SWP Financial LLC acquired a new stake in shares of Intuitive Surgical in the fourth quarter valued at approximately $255,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on ISRG. Stifel Nicolaus reaffirmed a “buy” rating and set a $420.00 price target on shares of Intuitive Surgical in a research report on Friday, March 15th. StockNews.com lowered Intuitive Surgical from a “buy” rating to a “hold” rating in a report on Thursday, February 29th. Wells Fargo & Company raised their price target on Intuitive Surgical from $363.00 to $416.00 and gave the company an “overweight” rating in a research note on Friday, January 19th. Barclays boosted their price target on Intuitive Surgical from $385.00 to $430.00 and gave the stock an “overweight” rating in a research report on Thursday, January 25th. Finally, Royal Bank of Canada increased their price objective on Intuitive Surgical from $400.00 to $432.00 and gave the company an “outperform” rating in a report on Wednesday, January 24th. Five research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $371.60.

Get Our Latest Report on Intuitive Surgical

Intuitive Surgical Stock Performance

Shares of ISRG opened at $382.36 on Wednesday. The firm has a market cap of $135.53 billion, a P/E ratio of 76.02, a price-to-earnings-growth ratio of 6.13 and a beta of 1.36. Intuitive Surgical has a 52 week low of $250.01 and a 52 week high of $403.76. The firm’s 50-day simple moving average is $386.60 and its 200 day simple moving average is $335.05.

Intuitive Surgical (NASDAQ:ISRGGet Free Report) last posted its earnings results on Tuesday, January 23rd. The medical equipment provider reported $1.60 EPS for the quarter, beating the consensus estimate of $1.48 by $0.12. The company had revenue of $1.93 billion for the quarter, compared to the consensus estimate of $1.89 billion. Intuitive Surgical had a return on equity of 13.11% and a net margin of 25.24%. The firm’s revenue for the quarter was up 16.6% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.91 earnings per share. As a group, equities analysts forecast that Intuitive Surgical will post 4.93 earnings per share for the current year.

About Intuitive Surgical

(Get Free Report)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

See Also

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.